首页> 外文期刊>European journal of clinical investigation >Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.
【24h】

Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.

机译:Toll样受体4在动脉粥样硬化疾病的发生和发展中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract The family of Toll-like receptors (TLRs) initiates an innate immune response after recognition of pathogen-associated molecular patterns (PAMPs). Evidence is accumulating that TLRs, and particularly TLR4, are important players in the initiation and progression of atherosclerotic disease. Not only exogenous ligands but also endogenous ligands that are expressed during arterial injury are recognized by TLR4. Mouse knockout studies and epidemiological studies of human TLR4 polymorphisms have demonstrated that the TLR4 might play a role in the initiation and progression of atherosclerosis. This review will summarize the latest progression in research on the role of TLR4 in arterial occlusive disease In addition, the potential of intervention in TLR4 signalling to influence progression of atherosclerotic disease is discussed. Eur J Clin Invest 2004; 34 (5): 328-334
机译:摘要识别病原体相关分子模式(PAMPs)后,Toll样受体(TLR)家族启动了先天免疫应答。越来越多的证据表明,TLR,尤其是TLR4在动脉粥样硬化疾病的发生和发展中起着重要的作用。 TLR4不仅识别动脉损伤期间表达的外源性配体,而且还识别内源性配体。小鼠基因敲除研究和人类TLR4多态性的流行病学研究表明,TLR4可能在动脉粥样硬化的发生和发展中起作用。这篇综述将总结TLR4在动脉闭塞性疾病中作用的最新研究进展。此外,还讨论了干预TLR4信号传导影响动脉粥样硬化疾病进展的潜力。 Eur J Clin Invest 2004; 34(5):328-334

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号